Agile Therapeutics
AGRX
AGRX was delisted on the 25th of March, 2024.
26 hedge funds and large institutions have $683K invested in Agile Therapeutics in 2022 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 7 increasing their positions, 5 reducing their positions, and 2 closing their positions.
350% more first-time investments, than exits
New positions opened: 9 | Existing positions closed: 2
40% more repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 5
37% more funds holding
Funds holding: 19 → 26 (+7)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
47% less capital invested
Capital invested by funds: $1.28M → $683K (-$599K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LPL Financial
San Diego,
California
|
+$202K |
| 2 |
BlackRock
New York
|
+$126K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
+$97.8K |
| 4 |
Millennium Management
New York
|
+$83.6K |
| 5 |
ASN
Advisory Services Network
Atlanta,
Georgia
|
+$37.4K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citigroup
New York
|
-$24.3K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$22K |
| 3 |
Jane Street
New York
|
-$11.5K |
| 4 |
Two Sigma Investments
New York
|
-$8.59K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$344 |
AGRX Hedge Fund Activity: Q3 2022 in Review
26 of the 5,828 institutional investors tracked by Wall St. Rank reported a position in Agile Therapeutics (AGRX) for Q3 2022, worth a combined $683K — down 47% from $1.28M a quarter earlier.
Buyers outnumbered sellers: 9 funds opened new AGRX positions and 2 closed out — a net gain of 7 holders — while 7 added to existing stakes and 5 trimmed.
The largest buyer was LPL Financial, opening a new position worth an estimated $202K. The largest seller was Citigroup, cutting an estimated $24.3K.
- 26 institutional investors held Agile Therapeutics (AGRX) as of Q3 2022, up from 19 in Q2 2022.
- Funds reported $683K of Agile Therapeutics stock for Q3 2022, down 47% quarter-over-quarter.
- 9 funds opened new Agile Therapeutics positions in Q3 2022 and 2 closed out, a net change of +7 holders.
- The largest Agile Therapeutics buyer in Q3 2022 was LPL Financial, an estimated $202K added.
- The largest Agile Therapeutics seller in Q3 2022 was Citigroup, an estimated $24.3K sold.
Based on aggregated 13F filings for Q3 2022.